Sevoflurane may not be a complete sigh of relief in COVID-19.
作者信息
Kaura Vikas, Hopkins Philip M
机构信息
Academic Unit of Anaesthesia, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Academic Unit of Anaesthesia, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
出版信息
Br J Anaesth. 2020 Dec;125(6):e487-e488. doi: 10.1016/j.bja.2020.09.012. Epub 2020 Sep 16.
Abstract
摘要
相似文献
1
Sevoflurane may not be a complete sigh of relief in COVID-19.七氟醚对于新型冠状病毒肺炎可能并非完全是令人松一口气的选择。
Br J Anaesth. 2020 Dec;125(6):e487-e488. doi: 10.1016/j.bja.2020.09.012. Epub 2020 Sep 16.
2
Sevoflurane, a sigh of relief in COVID-19?七氟醚，是新冠疫情中的一丝慰藉？
Br J Anaesth. 2020 Aug;125(2):118-121. doi: 10.1016/j.bja.2020.04.076. Epub 2020 May 1.
3
Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS.用于新型冠状病毒肺炎和急性呼吸窘迫综合征的吸入性挥发性镇静剂
Intensive Care Med. 2020 Aug;46(8):1563-1566. doi: 10.1007/s00134-020-06154-8. Epub 2020 Jun 25.
4
Malignant hyperthermia in the intensive care setting.重症监护环境下的恶性高热
Crit Care. 2014 Feb 26;18(2):411. doi: 10.1186/cc13744.
5
Does prolonged propofol sedation of mechanically ventilated COVID-19 patients contribute to critical illness myopathy?对机械通气的新冠肺炎患者进行长时间丙泊酚镇静是否会导致危重病性肌病？
Br J Anaesth. 2020 Sep;125(3):e334-e336. doi: 10.1016/j.bja.2020.05.056. Epub 2020 Jun 10.
6
Suspected malignant hyperthermia during sevoflurane anesthesia.七氟烷麻醉期间疑似恶性高热。
J Chin Med Assoc. 2007 Nov;70(11):507-10. doi: 10.1016/S1726-4901(08)70050-9.
7
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Aug 5;16(701):1442-1443.
8
Palliative care in advanced coronavirus disease in intensive care units.重症监护病房中晚期冠状病毒病的姑息治疗。
BMJ Support Palliat Care. 2020 Sep;10(3):340. doi: 10.1136/bmjspcare-2020-002338. Epub 2020 May 15.
9
Care for Critically Ill Patients With COVID-19.对新冠肺炎危重症患者的护理
JAMA. 2020 Apr 21;323(15):1499-1500. doi: 10.1001/jama.2020.3633.
10
Preparedness for COVID-19: in situ simulation to enhance infection control systems in the intensive care unit.新型冠状病毒肺炎（COVID-19）的准备工作：通过现场模拟加强重症监护病房的感染控制系统。
Br J Anaesth. 2020 Aug;125(2):e236-e239. doi: 10.1016/j.bja.2020.04.001. Epub 2020 Apr 10.
引用本文的文献
1
Sedation with Sevoflurane versus Propofol in COVID-19 Patients with Acute Respiratory Distress Syndrome: Results from a Randomized Clinical Trial.七氟醚与丙泊酚用于新型冠状病毒肺炎急性呼吸窘迫综合征患者镇静的随机临床试验结果
J Pers Med. 2023 May 31;13(6):925. doi: 10.3390/jpm13060925.
2
Inhaled Sedation with Volatile Anesthetics for Mechanically Ventilated Patients in Intensive Care Units: A Narrative Review.重症监护病房中机械通气患者使用挥发性麻醉剂进行吸入镇静：一项叙述性综述。
J Clin Med. 2023 Jan 30;12(3):1069. doi: 10.3390/jcm12031069.
3
Computational pharmacology: New avenues for COVID-19 therapeutics search and better preparedness for future pandemic crises.计算药理学：寻找 COVID-19 治疗方法的新途径，为未来的大流行危机做好更好的准备。
Biophys Chem. 2022 Nov;290:106891. doi: 10.1016/j.bpc.2022.106891. Epub 2022 Sep 11.
4
Inhaled Sedation for Invasively Ventilated COVID-19 Patients: A Systematic Review.有创通气的新冠肺炎患者的吸入镇静：一项系统评价
J Clin Med. 2022 Apr 29;11(9):2500. doi: 10.3390/jcm11092500.
5
Anaesthetic management of a known or suspected malignant hyperthermia susceptible patient.已知或疑似恶性高热易感患者的麻醉管理。
BJA Educ. 2021 Jun;21(6):218-224. doi: 10.1016/j.bjae.2021.01.003. Epub 2021 Feb 19.
本文引用的文献
1
Anaesthetic management of a known or suspected malignant hyperthermia susceptible patient.已知或疑似恶性高热易感患者的麻醉管理。
BJA Educ. 2021 Jun;21(6):218-224. doi: 10.1016/j.bjae.2021.01.003. Epub 2021 Feb 19.
2
Genomic Screening for Malignant Hyperthermia Susceptibility.恶性高热易感性的基因组筛查。
Anesthesiology. 2020 Dec 1;133(6):1277-1282. doi: 10.1097/ALN.0000000000003547.
3
Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.丹曲林钠治疗恶性高热危象的可及性：欧洲恶性高热协作组指南。
Br J Anaesth. 2020 Aug;125(2):133-140. doi: 10.1016/j.bja.2020.04.089. Epub 2020 Jun 24.
4
Sevoflurane, a sigh of relief in COVID-19?七氟醚，是新冠疫情中的一丝慰藉？
Br J Anaesth. 2020 Aug;125(2):118-121. doi: 10.1016/j.bja.2020.04.076. Epub 2020 May 1.
5
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.2019 冠状病毒病（COVID-19）的重症监护管理：挑战与建议。
Lancet Respir Med. 2020 May;8(5):506-517. doi: 10.1016/S2213-2600(20)30161-2. Epub 2020 Apr 6.
6
Mission Impossible or Mission Futile?: Estimating Penetrance for Malignant Hyperthermia.《不可能完成的任务还是徒劳无功的任务？：恶性高热的外显率估计》
Anesthesiology. 2019 Nov;131(5):957-959. doi: 10.1097/ALN.0000000000002884.
7
Has malignant hyperthermia really disappeared with halothane? Comment on Br J Anaesth 2017; 119: i44-52.恶性高热真的随着氟烷的使用而消失了吗？对《英国麻醉学杂志》2017年；119卷：i44 - 52页的评论
Br J Anaesth. 2018 Oct;121(4):980-981. doi: 10.1016/j.bja.2018.06.012. Epub 2018 Jul 20.
8
The use of charcoal filters in malignant hyperthermia: have they found their place?活性炭过滤器在恶性高热中的应用：它们找到了自己的用武之地吗？
Anaesthesia. 2019 Jan;74(1):13-16. doi: 10.1111/anae.14407. Epub 2018 Aug 8.
9
A review of the safety and efficacy of inhaled methoxyflurane as an analgesic for outpatient procedures.吸入甲氧氟烷作为门诊手术镇痛剂的安全性和有效性评价。
Br J Anaesth. 2018 May;120(5):1040-1048. doi: 10.1016/j.bja.2018.01.011. Epub 2018 Feb 12.
10
Malignant hyperthermia in the intensive care setting.重症监护环境下的恶性高热
Crit Care. 2014 Feb 26;18(2):411. doi: 10.1186/cc13744.
Zotero 插件